Whole genome sequencing revealed that the causative mutation was in breast cancer 2, early onset (brca2)/fancd1, a gene well known for its causative contributions to various cancers and genetic diseases such as Fanconi anemia (FA) [169]. Here, BRCA2 is linked to breast carcinoma.